Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial.

@article{Jenkins2002SolubleFI,
  title={Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial.},
  author={David J A Jenkins and Cyril W. C. Kendall and Vladimir Vuksan and Edward Vidgen and Tina L Parker and Dorothea A Faulkner and Christine Mehling and Marcella Garsetti and Giulio Testolin and Stephen C. Cunnane and Mary Ann A Ryan and Paul N. Corey},
  journal={The American journal of clinical nutrition},
  year={2002},
  volume={75 5},
  pages={834-9}
}
BACKGROUND The US Food and Drug Administration (FDA) approved health claims for 2 dietary fibers, beta-glucan (0.75 g/serving) and psyllium (1.78 g/serving), on the assumption that 4 servings/d would reduce cardiovascular disease risk. OBJECTIVE We assessed the efficacy of this dose of fibers in reducing serum lipid risk factors for cardiovascular disease. DESIGN Sixty-eight hyperlipidemic adults consumed a test (high-fiber) and a control low-fat (25% of energy), low-cholesterol (<150 mg/d… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 79 extracted citations

Effects of psyllium on metabolic syndrome risk factors.

Obesity reviews : an official journal of the International Association for the Study of Obesity • 2012
View 3 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…